El próximo día Lunes 26 de junio de 2014a las 13:00 horas se organiza en el marco de las XIII Jornadas de Avances en Hepatología, la conferencia perteneciente al ciclo de conferencias de IBIMA titulada “Obesity and the Liver”, que será impartida por el Prof. Guruprasad P. Aithal. Confiamos en vuestra participación.
- Co-Director of NIHR Nottingham Digestive Diseases Biomedical Research Unit, Nottingham, UK
Guru Aithal was introduced to research in 1996 and his studies on pharmacogenetics of warfarin and its clinical relevance stimulated the identification of striking genetic factors explaining the inter-individual variation in dose requirement. In 2007, FDA updated the prescribing information for warfarin to add that genetic information improves dosing. Further studies on genetic susceptibility to drug-induced liver injury including the discovery of strong association of HLA genotypes has enhanced the understanding of the key role adaptive immunity in the pathogenesis.
His research interests include drug-induced liver injury, non-alcoholic fatty liver disease, epidemiology of liver & biliary diseases and Hepatopacreatobiliary imaging. He has over 100 publications including those in Nature Genetics, Nature Review, Lancet, British Medical Journal, Gastroenterology and Hepatology